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ABSTRACT
Prebiotics are selectively fermentable dietary compounds that result in changes in
the composition and/or activity of the intestinal microbiota, thus conferring benefits
upon host health. In veterinary medicine, commercially available products containing
prebiotics have not been well studied with regard to the changes they trigger on the
composition of the gut microbiota. This study evaluated the effect of a commercially
available nutraceutical containing fructo-oligosaccharides (FOS) and inulin on the
fecal microbiota of healthy cats and dogs when administered for 16 days. Fecal
samples were collected at two time points before and at two time points during
prebiotic administration. Total genomicDNAwas obtained from fecal samples and 454-
pyrosequencing was used for 16S rRNA gene bacterial profiling. The linear discriminant
analysis (LDA) effect size (LEfSe) method was used for detecting bacterial taxa that may
respond (i.e., increase or decrease in its relative abundance) to prebiotic administration.
Prebiotic administration was associated with a good acceptance and no side effects (e.g.,
diarrhea) were reported by the owners. A low dose of prebiotics (50 mL total regardless
of body weight with the end product containing 0.45% of prebiotics) revealed a lower
abundance of Gammaproteobacteria and a higher abundance of Veillonellaceae during
prebiotic administration in cats, while Staphylococcaceae showed a higher abundance
during prebiotic administration in dogs. These differences were not sufficient to sepa-
rate bacterial communities as shown by analysis of weightedUniFrac distancemetrics. A
predictive approach of the fecal bacterial metagenome using Phylogenetic Investigation
of Communities by Reconstruction of Unobserved States (PICRUSt) also did not reveal
differences between the period before and during prebiotic administration. A second
trial using a higher dose of prebiotics (3.2 mL/kg body weight with the end product
containing 3.1% of prebiotics) was tested in dogs and revealed a lower abundance
of Dorea (family Clostridiaceae) and a higher abundance of Megamonas and other
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(unknown) members of Veillonellaceae during prebiotic administration. Again, these
changes were not sufficient to separate bacterial communities or predicted metabolic
profiles according to treatment. A closer analysis of bacterial communities at all time-
points revealed highly individualized patterns of variation. This study shows a high
interindividual variation of fecal bacterial communities from pet cats and dogs, that
these communities are relatively stable over time, and that some of this variation can
be attributable to prebiotic administration, a phenomenon that may be affected by
the amount of the prebiotic administered in the formulation. This study also provides
insights into the response of gut bacterial communities in pet cats and dogs during
administration of commercially available products containing prebiotics. More studies
are needed to explore potentially beneficial effects on host health beyond changes in
bacterial communities.
Subjects Bioinformatics, Microbiology, Veterinary Medicine, Gastroenterology and Hepatology,
Nutrition
Keywords Microbiota, Prebiotics, Health, 16S rRNA gene, Fructo-oligosaccharides, Inulin,
Feline, Canine, Veterinary medicine, Gastrointestinal health
INTRODUCTION
The digestive tract of cats and dogs is inhabited by millions of microorganisms (especially
bacteria) that exert a positive and vital effect on host health (Suchodolski, 2011). A large
number of articles are steadily being published showing the extent (e.g., in microbial
composition) and consequences (e.g., relationship of specific microbes with persistence of
clinical signs) of this symbiosis in health and during a variety of disease states and conditions
such as obesity, gastrointestinal inflammation, and diarrhea (Deusch et al., 2015; Guard
et al., 2015; Hand et al., 2013; Handl et al., 2013; Junginger et al., 2014; Kieler et al., 2016;
Minamoto et al., 2014; Minamoto et al., 2015; Song et al., 2013; Suchodolski et al., 2015).
These studies are supported by meta’omic analytic techniques (Morgan & Huttenhower,
2014) and powerful freely-available computational resources to analyze the generated data
(Navas-Molina et al., 2013).
Humans andothermammals, such as cats anddogs, donot have all the necessary enzymes
in their small intestinal tract capable of degrading several types of plant fibers (Flint et al.,
2012). Upon consumption and after traveling throughout the small intestine, some types
of these non-digestible fibers (e.g., fructo-oligosaccharides) are fermented by the bacterial
microbiota in the colon thus exerting a positive effect on the abundance of beneficial
bacterial groups (e.g., Lactobacillus and Bifidobacterium), intestinal motility, epithelial
cellular integrity, and microbial biochemical networks (Scott et al., 2015). Interestingly,
prebiotics appear to also influence distant sites such as bones and skin, apparently through
an increase of beneficial bacteria in the gut, and derived fermentation products from
this increase reaching target cells (Collins & Reid, 2016). Several research studies have
shown beneficial effects associated with the consumption of fiber on gut microbiota and
overall health (e.g., improvement of gut barrier integrity) in humans and other vertebrates
(Montalban-Arques et al., 2015).
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Prebiotics are non-digestible carbohydrates such as fructo-oligosaccharides (FOS),
galacto-oligosaccharides (GOS) and inulin that are currently added to several commercial
foods for cats and dogs. Studies have shown an effect of these ingredients on fecal microbial
composition, nutrient digestibility, and short-chain fatty acid concentrations, particularly in
dogs (Patra, 2011; Schmitz & Suchodolski, 2016; De Godoy, Kerr & Fahey, 2013). Domestic
cats are obligate carnivores but several studies support the hypothesis that microbial
fermentation inside the distal gut is significant and beneficial to the host (Rochus, Janssens
& Hesta, 2014). However, most of the published studies have researched the effect of
natural prebiotics (with and without processing, e.g., potato fiber, see Panasevich et al.,
2015) as opposed to commercial preparations containing these ingredients. This generates
an important gap in the prebiotic literature because commercial prebiotic preparations are
sold all over the world, thus exposing cats and dogs of all ages and with various clinical
conditions to its potential effects on gut microbial ecology and health. Moreover, prebiotics
should theoretically increase the abundance of certain bacterial groups (e.g., Lactobacillus
and Bifidobacterium) in the gut in order to be considered a prebiotic, given current
definitions of these dietary compounds (Gibson et al., 2010). The objective of this study
was to evaluate the effect of a commercially available product containing prebiotics on,
fecal bacterial composition of clinically healthy cats and dogs. The results of this work
show statistically significant differences in several bacterial groups that can be attributed to
prebiotic administration. This study also lyprovides relevant insights into the uniqueness
of baseline fecal bacterial populations and their highly individualized variability over time
and response upon prebiotic administration in pet cats and dogs.
METHODS
Ethics
All experimental procedures were authorized by the Animal Care and Use Committee
(AUP 2011–160) and the Clinical Research Review Committee at Texas A&M University
(CRRC 10–14) and written informed client consent was obtained from the owners of all
enrolled animals. Inclusion criteria included healthy (i.e., lack of clinical signs and good
physical condition) non-obese, client-owned pet cats and dogs. Owners were instructed to
feed their pets as usual without any supplement such as probiotics, prebiotics or vitamins.
Exclusion criteria included abnormal serum parameters that could indicate subclinical
abnormalities.
Trial 1 (cats and dogs)
Clinically healthy client-owned and non-obese cats (n= 12) and dogs (n= 12) were
enrolled (Table 1). Regardless of body weight, owners were instructed to feed 50 mL
(containing 225 mg of FOS and inulin) of Viyo Veterinary R© (proprietary mixture of
vegetable andmeat by-products, oils, vitamins andminerals containing 0.45% of prebiotics
or 4,500 mg per kg in the end product) once per day for 16 days (this was the original
dose recommended by the company). Although we deliberately did not control for the
amount of food eaten per day, for a 10 kg dog eating 200 g of food per day this original
dose would represent approximately 0.1% of dry matter intake. It should be noted that
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Table 1 Participant information (Trial 1, cats and dogs).
Cats IDs Final body weight
C2 4 years DSH 4.7 kg
C3 1 year 6 months DSH 6.2 kg
C4 6 years DSH 6.2 kg
C5 8 years DSH 5.2 kg
C8 2 years 6 months Tabby 4.2 kg
C10 4 years Siamese mix 5.1 kg
C11 5 years DSH 5.1 kg
C12 10 months Siberian 5.7 kg
C13 1 year 6 months Calico 2.8 kg
C14 1 year 2 months DSH 4.0 kg
Dogs IDs Age Breed
D3 1 year 5 months Doberman 28.1 kg
D4 10 years Rottweiler/Lab mix 33.3 kg
D5 4 years Boston Terrier 10.5 kg
D6 1 year 6 months Lab 25.3 kg
D7 5 years Lab mix 23.6 kg
D8 4 years Mixed 23.1 kg
D9 7 years Weimaraner 29.1 kg
D10 1 year 10 months Pembroke Welsh Corgi 10.6 kg
D11 7 months Mix hound/ Great Dane 25.6 kg
D12 9 months Australian Kelpie 16.0 kg
Notes.
DSH, Domestic Short Hair.
this prebiotic percentage of dry matter intake decreases proportionally to total dry matter
intake. For example, for a 20 kg dog eating 400 g of food this original dose of 50 mL would
only represent 0.06% prebiotic on a dry matter basis. Fecal samples were collected by
the owners at two time points before prebiotic administration (8 days and 1 day before
initiation of prebiotic administration) and again at two time points after initiation of
prebiotic administration (days 8 and 16 after initiation of prebiotic administration) (see
Fig. 1 for a timeline of our experimental design). Fecal samples were collected into special
fecal sample tubes (provided), placed into zip-lock bags (provided) and frozen as soon as
possible after collection. Samples were stored in the freezer until brought to our laboratory
within 1–8 h, where they were stored at −20 ◦C until DNA extraction. The administration
of 50 mL of Viyo Veterinary R© daily for 16 days was the original dose recommended by
the company in an effort to improve health by a modification in the gut microbiota (main
objective of this current study).
Trial 2 (dogs only)
Clinically healthy client-owned, non-obese dogs (n= 10) were enrolled (Table 2). Five of
these dogs also participated in trial 1 (Trial 2 started approximately 9 months after Trial 1,
therefore there is no risk on carryover effects). Owners were instructed to feed 3.2 ml/kg
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Figure 1 Timeline of experimental design and sampling for 16S bacterial profiling (marked with *).
Two fecal samples were collected before (days−8 and−1) and during prebiotic administration (days 8
and 16). The prebiotic was administered daily to each animal for a period of 16 days (grey area).
Table 2 Participant information (Trial 2, dogs only).
Dogs
IDs
Age Breed Final body
weight
Comments
D1 4 years 9 months Boston Terrier 10.5 kg Same as D5 in Trial 1
D3 8 years Weimaraner 29.5 kg Same as D9 in Trial 1
D4 11 years Mix 30.4 kg Same as D4 in Trial 1
D5 2 years 6 months Doberman 29.5 kg Same as D3 in Trial 1
D6 3 years 3 months Mixed 29.5 kg New dog
D7 11 months Dutch Shepherd 20.4 kg New dog
D8 9 months Welsh Pembroke Corgi 10 kg New dog
D9 1 year 9 months Australian Kelpie 18 kg Same as D12 in Trial 1
D11 1 year 6 months Australian Shepherd 16.7 kg New dog
D12 1 year 3 months Pit Bull mix 32 kg New dog
bodyweight (each mL containing 31 mg of FOS and inulin) of an especially formulated
preparation of Viyo Veterinary R© (containing 3.1% of prebiotics or 31,000 mg per kg in
the end product) once per day for 16 days. The new formula was designed in an effort
to reach high enough levels of prebiotics in the overall dry matter consumed that would
be expected to have an impact on the intestinal microbiota in all dogs without reaching
unfeasible amounts (in mL) of the product. For example, a 10 kg dog eating 200 g of food
per day would need to consume 32 mL of the product (equating to 992 mg of prebiotics)
and this new dose would represent approximately 0.5% of dry matter intake, while a 20 kg
dog eating 400 g of food per day would need to consume 60 mL of the product (equating
to 1,860 mg of prebiotics) and this new dose would also represent approximately 0.5% of
dry matter intake. Similarly to trial 1, fecal samples were collected at two time points before
prebiotic administration (8 days and 1 day before initiation of prebiotic administration)
and at two time points after initiation of prebiotic administration (days 8 and 16 after
initiation of prebiotic administration) (Fig. 1).
Questionnaire
All pet owners (trials 1 and 2) were provided with a questionnaire to record the following
parameters during the study period: acceptance of the prebiotic, attitude, appetite, drinking
behavior, defecation frequency, borborygmus, flatulence, as well as volume, consistency,
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and color of feces (Supplemental Information). This questionnaire has been used in other
studies from our research group (Rutz et al., 2004).
DNA extraction and 16S bacterial profiling
A bead-beating phenol-chloroform based-method was utilized to isolate total genomic
DNA from all fecal samples as described elsewhere (Suchodolski et al., 2005). Primers
specific for 16S rRNA genes were used to amplify the variable V4–V5 region as described
previously (Suchodolski et al., 2009). Fecal bacterial communities were evaluated using
454-pyrosequencing before and during prebiotic administration using a bacterial tag-
encoded FLX-titanium 16S rRNA gene amplicon pyrosequencing (bTEFAP) as described
previously for canine and feline fecal samples (Garcia-Mazcorro et al., 2011; Handl et al.,
2011). All sequences with their corresponding metadata information is freely available in
the Sequence Read Archive at the NCBI (SRP071082).
Sequence analysis
The open-source freely available bioinformatics pipeline Quantitative Insights into
Microbial Ecology (QIIME) v. 1.8 was used to perform microbiome analysis from raw
16S DNA sequencing data using default scripts unless otherwise noted (Caporaso et al.,
2010;Navas-Molina et al., 2013). The split_libraries.py was used to perform quality filtering
and demultiplexing (i.e., assignment of reads to samples). Operational Taxonomic Units
(OTUs) were assigned using two different approaches. First using UCLUST v.1.2.22
(Edgar, 2010) with an open reference script (pick_open_reference_otus.py, Rideout et al.,
2014) in QIIME for alpha and beta diversity. Note that this algorithm does not
necessarily discard sequences that do not match the reference 16S database, thus
allowing for an accurate OTU representation. Second, using a closed reference algorithm
(pick_closed_reference_OTUs.py) for further analysis using Phylogenetic Investigation of
Communities by Reconstruction of Unobserved States (PICRUSt) (Langille et al., 2013).
The GreenGenes 13_5 97% OTU representative 16S rRNA gene sequences was used as
the reference sequence collection (DeSantis et al., 2006). Both weighted and unweighted
UniFrac distances were used to investigate clustering of microbial communities (Lozupone
& Knight, 2005; Lozupone et al., 2007).
Statistical analysis
The linear discriminant analysis (LDA) effect size (LEfSe) method (Segata et al., 2011)
was used to find organisms that could explain the differences in bacterial communities
between the time periods before and during prebiotic administration. This method
uses non-parametric tests and has been shown to be able to capture microbial taxa
associated with class variables in several studies from our research groups (Garcia-
Mazcorro et al., 2016; Minamoto et al., 2015). The ANOSIM and Adonis tests included
in the compare_categories.py QIIME script were used to determine whether the grouping
of samples (i.e., microbial communities) according to treatment period (i.e., before and
during prebiotic administration) is statistically significant also in QIIME. An alpha of 0.05
was considered to reject null hypotheses.
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RESULTS
Viyo Veterinary R© was well accepted (i.e., all except two cats in trial 1 and one dog in trial 2
had a good or excellent acceptance of the product at all time points during administration
of the product, as perceived by the owners). No negative side effects from consuming
the prebiotic preparation, such as vomiting, abdominal pain, lethargy, changes in fecal
consistency, and/or diarrhea were reported by the owners. Briefly, 96% of all time points
either before or during prebiotic in both trials were reported as normal or better than
normal in all parameters measured that contained normal as a category. As perceived by
the owners, one cat in trial 1 had lose or pulpy feces throughout the whole study period (i.e.,
before and during prebiotic), and one dog had some flatulence also throughout the study
(in fact, this dog also participated in trial 2 and was also reported to present some flatulence
during the whole study period). In trial 1 two cats refused to consume the product and
were therefore excluded from the study. Also in trial 1, two dogs were excluded because of
serum cobalamin and folate concentrations that were below the lower limit of the reference
interval (1 dog) or microfilaria identified in the blood during the complete blood count
(1 dog).
Trial 1—cats
A total of 10 cats completed trial 1 (∼4,600 quality-filtered sequences per sample; average
442 nucleotides per sequence) (Table 1). Similar to other studies (Handl et al., 2011), the
fecal microbiota of cats was dominated by Firmicutes (median: 93.5%, range: 54.5–99.8%)
followed by smaller proportions of Bacteroidetes (median: 3.4%, range: 0–37.1%) and
other very low abundant groups (Fig. 2). Please note that each study reveals numbers
and proportions of different microbial taxa that are the result of a combination of factors
such as primers for 16S amplification, DNA extraction procedure, length of amplicon,
reference sequence collection used to assign taxonomy, and inter-individual variability.
The fecal microbiota in cats showed less intraindividual variability over time compared to
interindividual variability (Fig. 3). Interestingly, cat number 2 (C2) and cat number 5 (C5)
showed high increases in the relative abundance of Lactobacillales (mostly Lactobacillus
spp.) during prebiotic administration (Fig. 3), which is noteworthy given the historical
association of prebiotics with increased abundances of lactic acid bacteria.
The LEfSemethod showed that an unknownmember of the family Veillonellaceae (order
Clostridiales within Firmicutes)was significantly increased during prebiotic administration,
and also that an unknownmember ofGammaproteobacteriawas decreased during prebiotic
administration (Fig. 4). These changes, which involved samples from several individual cats
thus suggesting an effect of the prebiotic (Fig. 4), were not sufficient to cause a significant
difference in bacterial communities using weighted UniFrac distances (Fig. 5, please note
that the analysis of unweighted UniFrac distances revealed similar results). This lack of
significance is supported by high p-values in ANOSIM and Adonis tests (p> 0.5), even
though these tests are known to have very low specificity (i.e., these tests usually detect a
difference in microbial communities even when there is not necessarily a strong and clear
separation in PCoA plots). A predictive approach to investigate the functional microbiome
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Figure 2 Relative abundance of bacterial groups at the order level in trial 1. This figure displays column
charts that show the relative abundance of 16S sequences at the order level for cats (A) and dogs (B). Sam-
ples were organized based on the highest abundant order (Clostridiales). Box plots for the most abundant
orders are also shown (most bacterial groups did not show a statistical significant difference; see main text
for details). The x axis contains the sample names (C, cats; D, dogs, numbers imply the number of the an-
imal and the day of sampling (1, day−8, 2, day−1, 3, day 8; 4, day 16). For example, C13.3 implies cat
number 13, day 8 during prebiotic administration.
using PICRUSt did not reveal any significant difference between the period before and
during prebiotic administration (Supplemental Information).
Trial 1—dogs
A total of 10 dogs completed trial 1 (∼4,600 quality-filtered sequences per sample;
average 442 nucleotides per sequence). One sample (dog number 11 or D11, day 8 during
prebiotic administration) did not produce any sequence data and could not be used for
analysis. Similar to other studies (Handl et al., 2011), the fecal microbiota of dogs was
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Figure 3 Relative abundance of bacterial groups at the order level for each cat and dog in trial 1. The
sample names for cats (C) and dogs (D) are numbered depending on the animal ID (see Table 1). Bars
represent day 8 and 1 before prebiotic day 8 and 16 during prebiotic administration, in that order. Please
note that a sample corresponding to day 8 during prebiotic administration in Dog 11 (D11) could not be
analyzed.
dominated by Firmicutes (median: 93.2%, range: 70.2–98.8%) (Fig. 2) with each dog
also having unique patterns of fecal bacterial abundances showing stability over time
(Fig. 3). Two dogs (dog number 3, D3, and dog number 12, D12) showed high increases
in the order Lactobacillales during prebiotic administration (Fig. 3) although D12 did not
show the same increase in this bacterial group in trial 2 (see Trial 2 below). Interestingly,
another dog in trial 1 (dog number 7, D7) had very high abundances of Lactobacillales
at baseline (before prebiotic administration) and these abundances decreased to near
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Figure 4 Relative abundance of bacteria in cats in trial 1 before and during prebiotic administration.
The LEfSe method revealed a significant difference in the relative abundance of Gammaproteobacteria (A)
and Veillonellaceae (B) between the periods before and during prebiotic administration. Straight lines rep-
resent medians and dashed lines represent means.
0% at day 16 of prebiotic administration (Fig. 3). The LEfSe method showed that an
unknown member of Staphylococcaceae was higher during prebiotic administration,
while the genus Sutterella (family Alcaligenaceae in the order Burkholderiales within the
Betaproteobacteria) was higher (although less prevalent) before prebiotic administration
(Fig. 6). It is important to note that these differences were due to a few samples only
Garcia-Mazcorro et al. (2017), PeerJ, DOI 10.7717/peerj.3184 10/26
Figure 5 Principal Coordinate Analysis (PCoA) plot. PCoA plot of weighted UniFrac distances in cats
(trial 1). The lack of clustering by treatment was supported by ANOSIM and Adonis tests (p > 0.5, see
main text).
(especially for Staphylococcaceae), which were nonetheless enough for the LEfSe method
to detect a significant effect (Fig. 6). Similarly to cats, these differences were not sufficient
to significantly separate bacterial communities according to weighted UniFrac distances
(Fig. 7, unweighted UniFrac revealed similar results). Also similar to what was observed
in cats, a predictive approach to investigate the functional microbiome did not reveal any
significant difference between the period before and during prebiotic administration in the
dogs enrolled in trial 1 (Supplemental Information).
Trial 2—dogs only
Trial 2 was designed to explore the possibility that an increase in prebiotic content would
result in relevant changes in the fecal microbiota, with a focus on canine patients. A
total of 10 dogs completed trial 2 (∼3,200 quality-filtered sequences per sample; average
432 nucleotides per sequence). The fecal microbiota was again dominated by Firmicutes
although with much lower proportions compared to all dogs in trial 1 (median: 78.5% in
trial 2 vs. a median: 93.2% in trial 1) and with higher variability (range: 29.6–97.6% vs.
70.2–98.8% in trial 1) (Fig. 8). The reasons behind these differences in relative proportions
and variability in the phylum Firmicutes (and other bacterial groups) are unclear; for
example, 5 dogs participated in both trials but these dogs showed bacterial abundances
and over time variability (Fig. 9) that did not necessarily reflect those abundances and
variability in trial 1 (Fig. 3). Actually, dog 12 (D12) participated in both trials but only
showed increases in Lactobacillales in trial 1 (this dog was coded as dog number 9 or D9 in
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Figure 6 Relative abundance of bacteria in dogs in trial 1 before and during prebiotic administration.
The LEfSe method revealed a significant difference in the relative abundance of Staphylococcacea (A) and
Sutterella (B) between the periods before and during prebiotic administration. Straight lines represent me-
dians and dashed lines represent means.
trial 2). Interestingly, one dog in trial 2 (dog number 7, D7) had near 0% Bifidobacterium
at both time points before prebiotic administration, an increase to 8.4% on day 8 after
initiation of prebiotic administration, and a further increase to 25.9% on day 16 after
initiation of prebiotic administration (Fig. 9). This same dog (D7, trial 2) also had amassive
increase of Lactobacillaceae from <1% before and on day 8 after initiation of prebiotic
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Figure 7 Principal Coordinate Analysis (PCoA) plot. PCoA plot of weighted UniFrac distances in dogs
(trial 1). The lack of clustering by treatment was supported by ANOSIM and Adonis tests (p > 0.5, see
main text).
administration to 35.2% on day 16 after initiation, and Turicibacteraceae, from 0% before
prebiotic administration to 49% and 15% on days 8 and 16 after initiation of prebiotic
administration, respectively (Fig. 9).The LEfSemethod showed a lower abundance ofDorea
(family Clostridiaceae) and also higher abundances of Megamonas and other (unknown)
members of Veillonellaceae (class Negativicutes within the Firmicutes) during prebiotic
administration (Fig. 10). These changes involved samples from several individuals and
can therefore be considered associated with the prebiotic administration tested in trial 2
(Fig. 10). Similar to dogs in trial 1, these differences were not sufficient to significantly
separate bacterial communities according to weighted or unweighted UniFrac distances,
or to cause significant differences in the predicted functional microbiome (Supplemental
Information).
DISCUSSION
Prebiotics are non-digestible dietary ingredients with suggested health-bearing properties
that are included in several commercially available products for use in cats and dogs.
Sound scientific evidence shows that prebiotics can exert a positive effect on vertebrate
(including humans) health (Montalban-Arques et al., 2015), but this has not been well
studied in veterinary medicine, especially with regards to products that are commercially
available. This study evaluated the fecal bacterial microbiota in healthy cats and dogs that
were supplemented with a commercial prebiotic formulation containing FOS and inulin.
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Figure 8 Relative abundance of bacterial groups at the order level in trial 2. This figure displays column
charts that show the relative abundance of sequences at the order level for dogs (trial 2). Samples were or-
ganized based on the highest abundant order (Clostridiales). Box plots for the most abundant orders are
also shown (most bacterial groups did not show a statistically significant difference; see main text for de-
tails). The x axis contains the sample names (D, dog; numbers imply the number of the animal and the
day of sampling (1, day−8; 2, day−1; 3, day 8; 4, day 16)). For example, D5.2 implies dog number 5 day -
1 before prebiotic administration.
Our results support the fact that each individual animal (including humans) carries
a microbial community so specific that it resembles a fingerprint (Suchodolski et al.,
2005; Zoetendal, Akkermans & De Vos, 1998). In fact, research performed on the human
microbiota has demonstrated the feasibility of microbiome-based identifiability of single
individuals (Franzosa et al., 2015). While the factors associated with this uniqueness
are a matter of debate, several studies in humans have shown that host genetics exert
a great influence (Benson et al., 2010; Blekhman et al., 2015), although diet may indeed
outweigh the effects of host genetic background (Dabrowska & Witkiewicz, 2016;Wu et al.,
2011). This microbial uniqueness is particularly important to clinicians (both human and
veterinary) because it also implies individualized responses to treatment (Topol, 2014),
for example to antibiotic administration (Dethlefsen & Relman, 2011; Igarashi et al., 2014;
Suchodolski et al., 2009). Unfortunately, guidelines for prebiotic administration are often
unclear (i.e., companies usually suggest the same dose regardless of body weight, age,
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Figure 9 Relative abundance of bacterial groups at the order level for each dog in trial 2. The sample
names are numbered depending on the animal ID (see Table 1). Within parenthesis, we also included the
dog’s ID based on trial 1. Bars represent day 8 and 1 before prebiotic and day 8 and 16 during prebiotic
administration, in that order.
clinical condition, etc.) and have not fully considered the uniqueness of each gut microbial
ecosystem (Barzegari & Saei, 2012).
While the individuality of gut microbial communities with regard to their response
to prebiotic administration is a relevant matter for daily clinical use of these increasingly
utilized nutraceutical ingredients, very few studies have discussed the uniqueness of native
bacterial communities in individual cats or dogs, their variability over time or during
the course of particular treatments (Garcia-Mazcorro et al., 2012a; Garcia-Mazcorro et
al., 2012b; Ritchie, Steiner & Suchodolski, 2008; Suchodolski et al., 2005). In this study, two
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Figure 10 Relative abundance of bacteria in dogs in trial 2 before and during prebiotic administration.
The LEfSe method revealed a significant difference in the relative abundance of Dorea (A),Megamonas
(B), and Veillonellacea (C) between the periods before and during prebiotic administration. Straight lines
represent medians and dashed lines represent means.
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cats and two dogs showed increases in the relative abundance of Lactobacillales (Fig. 3),
suggesting that these animals are highly responsive individuals to the prebiotic tested (at
least with regards to Lactobacillaes). Also in trial 1, one dog had very high abundances of
Lactobacillales at baseline (i.e., before prebiotic) but showed a marked decrease to near 0%
at day 16 of prebiotic administration (D7, Fig. 3). While these results suggest a relationship
between baseline bacterial populations and response to prebiotics, this phenomenon has
received very little attention (Garcia-Mazcorro et al., 2011; Stecher et al., 2010; Arciero et
al., 2010; Vitali et al., 2009). For example, Vitali et al. (2009) mention that the significant
increase of a bacterial group (i.e., Lactobacillus helveticus) after administration of a synbiotic
(containing fructo-oligosaccharides, L. helveticus and Bifidobacterium longum) was directly
linked to the low incidence of this group in the intestine of the human host, thus implying
a potential relationship between the native bacterial groups and any other group that is
being supplemented in the form of probiotics or that increases due to the presence of
prebiotics. In support of this hypothesis, one dog in trial 2 (dog number 7, D7) had near
0% Bifidobacterium at baseline before prebiotic administration but showed a remarkable
increase of this bacterial group on day 16 after initiation of prebiotic administration
(Fig. 9), suggesting that this dog may also be considered a highly responsive individual to
the prebiotic tested. Overall, our results support the concept that the native microbiota in
each individual cat or dog is unique and that this microbiota show highly individualized
patterns of variation over time and during the course of prebiotic administration.
In addition to confirming the uniqueness of fecal microbiota in individual cats and dogs,
this study also confirms previous observations about the minimal effects of low prebiotic
dosages on the gut microbiota of healthy cats (Sparkes et al., 1998; Kanakupt et al., 2011)
and dogs (Willard et al., 1994;Willard et al., 2000; Barry et al., 2009;Vanhoutte et al., 2005).
This minimal effect of prebiotics on the gut microbial ecosystem is a common result when
administering low doses of prebiotics (∼1% of dry matter) but higher doses have shown a
potential to promote a more generalized effect of these ingredients in both cats (Barry et al.,
2010) and dogs (Middelbos et al., 2010). However, conflicting results have been presented
in the literature where different amounts of dietary fiber (0.5, 1, 2, 4, and 8%) were not
associated with differences in the abundance of different microorganisms (Faber et al.,
2011). Nonetheless, these and other similar studies often lack sufficient representativeness
with regard to complex microbiota (i.e., most reports only studied one or a few organisms
while hundreds of different microorganisms exist and cohabit the intestinal tract of
cats and dogs) and some only used culture techniques, which are considered obsolete in
contemporary studies of microbial ecology (Ritz, 2007). Indeed, studies such as this current
investigation that uses high-throughput sequencing allows us to investigate the majority of
all bacterial groups at once, thus offering valuable insights to current prebiotic literature
in small veterinary practice.
The dose of prebiotics offered to each individual patient is a matter of debate in human
and veterinary medicine. There are at least three possible ways to administer prebiotics
to cats and dogs in real life. First, prebiotics can be offered as a fixed percentage of dry
matter. Indeed, most well-controlled prebiotic papers in cats and dogs report the dose
of prebiotics in percentage of dry matter intake, varying from 0% to 7% (Patra, 2011). A
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potential issue with this way of administering prebiotics (i.e., as percentage of dry matter)
is that the amount of food consumed by a given pet cat or dog may vary substantially over
time (e.g., accordingly to age) and among different animals (e.g., two dogs, each weighting
10 kg, may consume different amounts of food). Therefore, in a real-life scenario (not
a controlled setting) two individual animals having the same body weight may consume
different amounts of total prebiotics in their diets, not because of the prebiotic percentage
of dry matter but because of the different amounts of food consumed. Second, a fixed
amount of prebiotics can be offered regardless of dry matter intake, age, body weight,
and all other specific characteristics of the animal. For example, 50 mL were offered in
trial 1 regardless of body weight and the amount of food consumed each day to each cat
and dog (please note that this was original dose provided by the company). This dose has
the disadvantage that the amount of prebiotic offered would decrease proportionally to
the amount of food consumed. Finally, another way of administering prebiotics can be
based on other parameters aside dry matter intake. For example, trial 2 was designed to
equilibrate the amount of prebiotics for each dog, using a straightforward parameter (i.e.,
body weight). Interestingly, in this current study we report increases in important bacterial
groups for gut health such as Veillonellacea (Suchodolski et al., 2012) only in trial 2. This
discussion and the data generated by this current study may be relevant to guide other
studies addressing the effect of products containing prebiotics offered to cats and dogs.
Our study evaluated a product that, together with other prebiotic formulations, are
currently marketed to all breeds of cats and dogs of all ages, sizes and clinical conditions.
Therefore, our study adds relevant information for the potential effect of commercial
prebiotics. Nonetheless, there are at least five potential limitations of this study that are
important to discuss for guiding future efforts in using prebiotics to improve intestinal
health in cats and dogs. First, in this study we included a highly diverse group of animals,
which may have influenced the response or lack thereof to prebiotic administration. The
inclusion of a more homogeneous group of animals may have diminished this variability
and therefore make the effect of prebiotic administration easier to detect. However, this
is not always the case. For example, a recent study showed a minimal effect of potato
fiber on the fecal microbiota of dogs using a homogeneous group of animals (all female
with hound bloodlines and similar age and body weight) (Panasevich et al., 2015). In this
study we deliberately included different dogs to mimic a real life scenario. Second, in this
study we deliberately did not force the owners to feed a specific amount of food per day
but instead we asked them to continue their regular feeding habits. This is important to
investigate native microbial communities and their fluctuations in ordinary pets, which
are the ultimate consumers of nutraceuticals containing prebiotics. Third, in this study
we only used one molecular technique (i.e., high-throughput sequencing) to assess the
fecal microbiota, and other studies have shown that the results from this technique do not
always correlate with the results of other molecular techniques such as fluorescent in situ
hybridization (Garcia-Mazcorro et al., 2012a; Garcia-Mazcorro et al., 2012b). Nonetheless,
other studies have shown that sequencing results correlate well with the results obtained
from other molecular techniques such as quantitative real-time PCR (Minamoto et al.,
2015; Panasevich et al., 2015). Fourth, commercial prebiotic formulations such as the one
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used in this study contains a mixture of ingredients aside the prebiotic component that
makes it difficult to study the effect of the prebiotics independently. Lastly, in this study
we only evaluated the bacterial microbiota but the fungal microbiota does indeed deserve
investigation (Handl et al., 2011).
In summary, there is a potential beneficial effect of prebiotics to improve gut health in
cats and dogs and this effect may be mediated by changes in the gut microbiota (Schmitz
& Suchodolski, 2016). This study reinforces the notion that individual cats and dogs have
a unique fecal microbiota, which is relatively stable over time and responds differently
to dietary manipulation using prebiotics and possibly other dietary compounds. Also,
this study shows that the consumption of up to 31 mg/kg body weight of prebiotics (a
mixture of FOS and inulin) does not significantly change the abundance of most bacterial
groups in feces of healthy dogs. Exceptions include bacterial groups such as Dorea,
Megamonas, Sutterela, Veilloneceae, Staphylococcaceae, and Gammaproteobacteria, which
deserve attention because the changes observed in this study (although largely driven
by individual responses) were not accompanied by negative side effects. Veillonellaceae
deserves particular attention because it showed increased abundances during prebiotic
administration in cats (trial 1) and dogs (trial 2) in this current study and other studies have
shown that this group is depleted in the duodenum of dogs with idiopathic inflammatory
bowel disease (Suchodolski et al., 2012) and is highly responsive to dietary challenges
(Bonder et al., 2016), including consumption of soluble corn fiber and polydextrose in
humans (Hooda et al., 2012) and inulin in dogs (Beloshapka et al., 2013). Importantly, this
study was not performed in a controlled setting; therefore controlled studies with control of
diet, environment and individual characteristics of the animals such as breed and age, may
help to draw more conclusive evidence about the effect of prebiotics on the gut microbiota
of pet cats and dogs. Our current study does not rule out other mechanisms by which the
evaluated product may confer a health benefit to the host (e.g., increased production of
short-chain fatty acids), but more studies are needed to prove this and to study in more
detail the effect of this and other commercially available products containing prebiotics for
cats and dogs. Moreover, more studies are needed to explore potentially beneficial effects
on host health beyond changes in bacterial communities such as increased expression of
immunoregulators in the intestinal mucosa (e.g., cytokines).
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